Bryan Garnier European Healthcare Conference 2020 – virtual event

GenSight Biologics reports validation of LUMEVOQ® Marketing Authorisation Application (MAA) by European Medicines Agency

Eyecelerator 2020 – Virtual Conference

GenSight Biologics successfully raises €25 million in an oversubscribed private placement with US and European institutional investors

GenSight Biologics launches a capital increase of approximately €25 million by means of an accelerated bookbuilding process

BioEurope – Digital

4th Annual Gene Therapy for Rare Disorders Europe – Virtual

GenSight Biologics Reports Cash Position as of September 30, 2020 and Provides Operational Update

GenSight Biologics Appoints Elsy Boglioli to its Board of Directors

Cell & Gene Meeting on the Mesa – Virtual